肺癌筛查与管理中国专家共识

Chinese expert consensus on screening and management of lung cancer

我国肺癌发病率及病死率均居恶性肿瘤之首,5年生存率仅为19.7%.要想解决肺癌防治的诸多问题,关键需要进一步推广和完善肺癌筛查及早诊早治策略.中国肺癌防治联盟、中华医学会呼吸病学分会肺癌学组携手国内呼吸科、胸外科和影像学科等相关领域知名专家在"肺结节诊治中国专家共识(2018年版)"基础上,参考了国内外最新研究成果和各学科相关指南及共识,制定本共识.在传统"4P"疾病诊治模式的基础上,本共识增加了"5P"精准医学及液体活检的内容,旨在更好地体现基于遗传背景与环境差异的个体化肺癌筛查特点.本共识除了对现有肺癌筛查技术进行详尽介绍外,也对肺癌筛查全程管理进行系统阐述.此外,物联网医学具备全面感知、可靠传输和智能处理等功能,筛查过程中可辅助预测、检测和诊断,制定精准的筛查方案和调动患者参与性,其在肺癌筛查全程管理中的潜能被充分体现.力求真正做到精准筛查、防治和全程管理,从而更好地预防肺癌发生及改善肺癌5年生存率.

The incidence and mortality of lung cancer in China are the highest in all malignant tumors,and the five-year survival rate is only 19.7%.In order to solve the problems in the prevention and treatment of lung cancer,it is necessary to promote and improve the screening,early diagnosis and treatment strategies for lung cancer.Chinese Alliance Against Lung Cancer,Chinese Medical Association of Respiratory Disease Branch Lung Cancer Study Group and well-known experts in the fields of respiratory,thoracic surgery and imaging,develop this consensus based on"chinese expert consensus for diagnosis and treatment of pulmonary nodules(2018 version)"and the latest research results at home and abroad.Based on the traditional"4P"disease diagnosis and treatment model,this consensus has added the content of"5P"precision medicine and liquid biopsy,aiming to better reflect the characteristics of individualized lung cancer screening based on genetic background and environmental differences.In addition to a detailed introduction to the existing lung cancer screening technology,the consensus also systematically elaborates on the whole process of lung cancer screening and management.Furthermore,medical internet of things(MIoTs)has comprehensive sensing,reliable transmission and intelligent processing functions.MIoTs can assist in prediction,detection and diagnosis during the screening process,develop accurate screening programs and mobilize patient participation.The potential application of MIoTs in the whole process of lung cancer screening is fully reflected.We strive to achieve accurate screening,prevention and management,and to manage the whole process,so as to better prevent lung cancer and improve the five-year survival rate of lung cancer.